Preferentially Expressed Antigen in Melanoma (PRAME) Peptide
PRAME
Reactivité: Mammifères
Hôte: Synthetic
BP, WB, IHC
N° du produit ABIN936776
Aperçu rapide pour Preferentially Expressed Antigen in Melanoma (PRAME) Peptide (ABIN936776)
Antigène
PRAME
(Preferentially Expressed Antigen in Melanoma (PRAME))
Origine
Mammifères
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Type de proteíne
- Synthetic
-
Séquence
- AMVQAWPFTC LPLGVLMKGQ HLHLETFKAV LDGLDVLLAQ EVRPRRWKLQ
-
Attributs du produit
-
A synthetic peptide for use as a blocking control in assays to test for specificity of PRAME antibody,
Alternative Names: PRAME control peptide, PRAME antibody Blocking Peptide, Anti-PRAME Blocking Peptide, Preferentially Expressed Antigen In Melanoma Blocking Peptide, MAPE Blocking Peptide, OIP4 Blocking Peptide
-
-
-
-
Indications d'application
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20 °C long term.
-
-
- PRAME (Preferentially Expressed Antigen in Melanoma (PRAME))
-
Sujet
- PRAME functions as a transcriptional repressor, inhibiting the signaling of retinoic acid through the retinoic acid receptors RARA, RARB and RARG. PRAME prevents retinoic acid-induced cell proliferation arrest, differentiation and apoptosis.
-
Poids moléculaire
- 56 kDa
Antigène
-
Vous êtes ici:
